United-Guardian - 26 Year Stock Price History | UG

Historical daily share price chart and data for United-Guardian since 1992 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for United-Guardian as of October 22, 2018 is 17.15.
United-Guardian Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 18.0052 17.6985 19.7500 15.7500 17.1527 -4.92%
2017 14.9823 13.9855 19.1498 12.4466 18.0398 28.57%
2016 15.1812 17.5631 19.7088 12.0598 14.0307 -15.32%
2015 16.1396 16.0373 19.2151 14.9001 16.5682 1.38%
2014 21.0128 22.3673 27.5333 15.4151 16.3422 -27.47%
2013 18.8966 15.4363 23.0310 14.5399 22.5328 48.42%
2012 13.3121 10.8274 17.3976 10.7696 15.1816 37.82%
2011 10.2096 9.7989 11.0152 9.0957 11.0152 14.82%
2010 8.3186 7.5101 10.3009 7.3534 9.5933 27.96%
2009 5.7432 5.5707 7.6858 3.6111 7.4970 32.24%
2008 6.1333 6.1215 7.4333 4.5376 5.6693 -6.59%
2007 5.9172 4.7633 8.2985 4.7355 6.0691 20.91%
2006 4.9490 4.7432 5.7766 4.1112 5.0197 6.55%
2005 4.1819 4.2131 5.8721 3.5160 4.7113 12.49%
2004 3.4171 3.7134 4.1881 2.6727 4.1881 13.36%
2003 3.0242 1.9134 4.0637 1.8577 3.6945 89.40%
2002 2.3055 2.3546 3.3282 1.4716 1.9506 -17.16%
2001 2.4103 1.9992 3.3098 1.9992 2.3546 28.48%
2000 1.9456 1.6265 2.4940 1.4639 1.8326 20.72%
1999 1.6604 1.8022 2.0142 1.1661 1.5181 -20.44%
1998 2.0003 1.7267 2.7732 1.4651 1.9082 7.26%
1997 1.5161 0.7245 2.5356 0.7245 1.7790 145.55%
1996 0.8341 0.6533 1.2602 0.6291 0.7245 10.90%
1995 0.7924 0.7299 0.9839 0.6049 0.6533 -10.49%
1994 1.3550 1.7662 2.2179 0.6049 0.7299 -56.80%
1993 2.0961 2.6211 2.8227 1.5122 1.6896 -32.96%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.080B $0.013B
UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.867B 19.45
Abbott Laboratories (ABT) United States $118.574B 24.05
Stryker (SYK) United States $63.182B 24.41
Boston Scientific (BSX) United States $50.532B 26.29
Baxter (BAX) United States $37.110B 25.26
Zimmer Biomet Holdings (ZBH) United States $25.314B 16.26
ResMed (RMD) United States $14.694B 29.17
Smith & Nephew SNATS (SNN) United Kingdom $14.608B 0.00
Canopy Growth (CGC) Canada $10.780B 0.00
Perrigo (PRGO) Ireland $9.837B 13.96
Bio-Rad Laboratories (BIO) United States $8.382B 53.82
Hill-Rom Holdings (HRC) United States $5.797B 19.66
Haemonetics (HAE) United States $5.495B 50.15
ICU Medical (ICUI) United States $5.418B 36.71
Insulet (PODD) United States $5.203B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.301B 0.00
Hutchison China MediTech (HCM) China $4.012B 0.00
Agios Pharmaceuticals (AGIO) United States $3.879B 0.00
Neogen (NEOG) United States $3.281B 49.69
NuVasive (NUVA) United States $3.191B 30.27
National Vision Holdings (EYE) United States $3.137B 69.28
Quidel (QDEL) United States $2.525B 51.73
NxStage Medical (NXTM) United States $1.815B 0.00
Phibro Animal Health (PAHC) United States $1.784B 25.40
Cardiovascular Systems (CSII) United States $1.263B 727.80
AtriCure (ATRC) United States $1.071B 0.00
VAREX IMAGING (VREX) United States $0.985B 16.09
Owens & Minor (OMI) United States $0.934B 9.99
OraSure Technologies (OSUR) United States $0.904B 59.08
Cerus (CERS) United States $0.887B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.874B 25.81
PetIQ (PETQ) United States $0.862B 28.18
Surmodics (SRDX) United States $0.842B 101.77
MacroGenics (MGNX) United States $0.792B 0.00
Omeros (OMER) United States $0.770B 0.00
Insys Therapeutics (INSY) United States $0.662B 0.00
Meridian Bioscience (VIVO) United States $0.660B 22.57
LeMaitre Vascular (LMAT) United States $0.542B 26.97
Lantheus Holdings (LNTH) United States $0.517B 16.07
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.445B 0.00
Quanterix (QTRX) United States $0.398B 0.00
Evolus (EOLS) United States $0.354B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.323B 0.00
Cytosorbents (CTSO) United States $0.321B 0.00
Surface Oncology (SURF) United States $0.220B 0.00
Rockwell Medical (RMTI) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.204B 0.00
Chimerix (CMRX) United States $0.173B 0.00
Fonar (FONR) United States $0.149B 7.32
Conatus Pharmaceuticals (CNAT) United States $0.144B 0.00
Chembio Diagnostics (CEMI) United States $0.137B 0.00
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.31
Imprimis Pharmaceuticals (IMMY) United States $0.070B 0.00
Neurotrope (NTRP) United States $0.057B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00